IPCA LABORATORIES
Back to Income Statement
|
IPCA LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹8,897 Cr | ₹7,662 Cr | ₹6,204 Cr | ₹5,797 Cr | ₹5,395 Cr |
What is the latest Revenue of IPCA LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹8,897 Cr |
| Mar2025 | ₹7,662 Cr |
| Mar2024 | ₹6,204 Cr |
| Mar2023 | ₹5,797 Cr |
| Mar2022 | ₹5,395 Cr |
How is Revenue of IPCA LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,897 Cr | 16.11 | |
| Mar2025 | ₹7,662 Cr | 23.50 | |
| Mar2024 | ₹6,204 Cr | 7.03 | |
| Mar2023 | ₹5,797 Cr | 7.45 | |
| Mar2022 | ₹5,395 Cr | - | |
Compare Revenue of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹42,678.7 Cr | -5.2% | -5.5% | 16.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -5.2% |
-5.5% |
16.2% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses